S.Amdt. 1238
What it does: Rewrites section 917(a)(b)(1)What it changes
1 change to H.R. 1256
Rewrites section 917(a)(b)(1)
ReplacesSection 917(a)(b)(1) of the Federal Food, Drug, and Cosmetic Act (as added by section 101)Removes section 917(a)(b)(1).
Inserted: (a) Establishment.--Not later than 6 months after the date of enactment of the Family Smoking Prevention and Tobacco Control Act, the Secretary shall establish a 14-member advisory committee, to be known as the Tobacco Products Scientific Advisory Committee (in this section referred to as the 'Advisory Committee').
Inserted: (b) Membership.--
Inserted: (1) In general.--
Inserted: (A) Members.--The Secretary shall appoint as members of the Tobacco Products Scientific Advisory Committee individuals who are technically qualified by training and experience in medicine, medical ethics, science, or technology involving the manufacture, evaluation, or use of tobacco products, who are of appropriately diversified professional backgrounds. The committee shall be composed of--
Inserted: (i) 7 individuals who are physicians, dentists, scientists, or health care professionals practicing in the area of oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, or any other relevant specialty;
Inserted: (ii) 1 individual who is an officer or employee of a State or local government or of the Federal Government;
Inserted: (iii) 1 individual as a representative of the general public;
Inserted: (iv) 1 individual as a representative of the interests of the tobacco manufacturing industry;
Inserted: (v) 1 individual as a representative of the interests of the small business tobacco manufacturing industry, which position may be filled on a rotating, sequential basis by representatives of different small business tobacco manufacturers based on areas of expertise relevant to the topics being considered by the Advisory Committee; and
Inserted: (vi) 3 individuals as representatives of the interests of the tobacco growers, with 1 such individual representing flu tobacco, one such individual representing burley tobacco, and one such individual representing dark tobacco.
Inserted: (B) Conflicts of interest.--No members of the committee, other than members appointed pursuant to clauses (iv), (v), and (vi) of subparagraph (A) shall, during the member's tenure on the committee or for the 18-month period prior to becoming such a member, receive any salary, grants, or other payments or support from any business that manufactures, distributes, markets, or sells cigarettes or other tobacco products.
Original wording
In section 917 of the Federal Food, Drug, and Cosmetic Act (as added by section 101) strike subsections (a) and (b)(1) and insert the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 1238. Mr. BUNNING submitted an amendment intended to be proposed by him to the bill H.R. 1256, to protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States Code, to make certain modifications in the Thrift Savings Plan, the Civil Service Retirement System, and the Federal Employees' Retirement System, and for other purposes; which was ordered to lie on the table; as follows:
In section 917 of the Federal Food, Drug, and Cosmetic Act (as added by section 101) strike subsections (a) and (b)(1) and insert the following:
“(a) Establishment.--Not later than 6 months after the date of enactment of the Family Smoking Prevention and Tobacco Control Act, the Secretary shall establish a 14-member advisory committee, to be known as the Tobacco Products Scientific Advisory Committee (in this section referred to as the ‘Advisory Committee').
“(b) Membership.--
“(1) In general.--
“(A) Members.--The Secretary shall appoint as members of the Tobacco Products Scientific Advisory Committee individuals who are technically qualified by training and experience in medicine, medical ethics, science, or technology involving the manufacture, evaluation, or use of tobacco products, who are of appropriately diversified professional backgrounds. The committee shall be composed of--
“(i) 7 individuals who are physicians, dentists, scientists, or health care professionals practicing in the area of oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, or any other relevant specialty;
“(ii) 1 individual who is an officer or employee of a State or local government or of the Federal Government;
“(iii) 1 individual as a representative of the general public;
“(iv) 1 individual as a representative of the interests of the tobacco manufacturing industry;
“(v) 1 individual as a representative of the interests of the small business tobacco manufacturing industry, which position may be filled on a rotating, sequential basis by representatives of different small business tobacco manufacturers based on areas of expertise relevant to the topics being considered by the Advisory Committee; and
“(vi) 3 individuals as representatives of the interests of the tobacco growers, with 1 such individual representing flu tobacco, one such individual representing burley tobacco, and one such individual representing dark tobacco.
“(B) Conflicts of interest.--No members of the committee, other than members appointed pursuant to clauses (iv), (v), and (vi) of subparagraph (A) shall, during the member's tenure on the committee or for the 18-month period prior to becoming such a member, receive any salary, grants, or other payments or support from any business that manufactures, distributes, markets, or sells cigarettes or other tobacco products.”.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
June 3, 2009